(Q44800855)

6 December 2017

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients (English)

1 reference

6 December 2017

0 references

1 reference

1 reference

Carlos Paya

1

1 reference

6 December 2017

Atul Humar

2

1 reference

6 December 2017

Ed Dominguez

3

1 reference

6 December 2017

Kenneth Washburn

4

1 reference

6 December 2017

Emily Blumberg

5

1 reference

6 December 2017

Barbara Alexander

6

1 reference

6 December 2017

Richard Freeman

7

1 reference

6 December 2017

Nigel Heaton

8

1 reference

6 December 2017

Mark D Pescovitz

9

1 reference

6 December 2017

Valganciclovir Solid Organ Transplant Study Group

10

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

American Journal of Transplantation

6 December 2017

1 reference

6 December 2017

4

1 reference

6 December 2017

4

1 reference

6 December 2017

611-620

1 reference

The indirect effects of cytomegalovirus infection on the outcome of organ transplantation

6 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seropositive donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

Oral ganciclovir dosing in transplant recipients and dialysis patients based on renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

Pharmacokinetics of valganciclovir and ganciclovir in renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

A systematic review of the associations between dose regimens and medication compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00382.X

10.1111/J.1600-6143.2004.00382.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference